Literature DB >> 25784516

Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation.

Patrizio Lancellotti1, Julien Magne2, Raluca Dulgheru2, Arnaud Ancion2, Christophe Martinez2, Luc A Piérard2.   

Abstract

In patients with heart failure, exercise echocardiography can help in risk stratification and decision making. The prognostic significance of exercise pulmonary hypertension (PH) in patients with secondary mitral regurgitation (MR) remains unknown. The aim of the present study was to assess the prognostic value of exercise PH in patients with secondary MR and narrow QRS intervals. From 2005 to 2012, 159 consecutive patients with secondary MR, narrow QRS intervals, left ventricular dysfunction (mean ejection fraction 36 ± 7%), and measurable systolic pulmonary arterial pressure (SPAP) during exercise echocardiography were included. Resting and exercise PH were defined as SPAP >50 and >60 mm Hg, respectively. Exercise PH was more frequent than resting PH (40% vs 13%, p <0.0001). On multivariate logistic regression, the independent determinants of exercise PH were resting SPAP (p <0.0001), exercise MR severity (p <0.0001), and e'-wave velocity (p = 0.004). The incidence of cardiac events during follow-up was significantly higher in patients with exercise PH compared with those without exercise PH (4 years: 40 ± 7% vs 20 ± 5%, p <0.0001). Patients with exercise PH exhibited higher rates of cardiac events and death than those with resting PH. In a multivariate Cox proportional hazards model, exercise PH was independently associated with the occurrence of cardiac events (p <0.0001). In conclusion, in patients with secondary MR, exercise PH is determined mainly by resting SPAP, left ventricular diastolic burden, and exercise MR severity. Exercise PH is a powerful predictor of poor outcomes, with a 5.3-fold increased risk for cardiac-related death during follow-up. These results highlight the added value of exercise echocardiography in secondary MR.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25784516     DOI: 10.1016/j.amjcard.2015.02.028

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Pulmonary hypertension: a long-term risk stratifier in primary mitral regurgitation.

Authors:  Mi-Jeong Kim; Hae Ok Jung
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Exercise echocardiography for structural heart disease.

Authors:  Masaki Izumo; Yoshihiro J Akashi
Journal:  J Echocardiogr       Date:  2016-01-13

3.  Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.

Authors:  Philippe B Bertrand; Ehud Schwammenthal; Robert A Levine; Pieter M Vandervoort
Journal:  Circulation       Date:  2017-01-17       Impact factor: 29.690

4.  Valvular disease: Prognostic relevance of pulmonary hypertension in valvular disease.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

5.  Exercise Doppler echocardiography for the diagnosis of pulmonary hypertension: renewed interest and evolving roles.

Authors:  Yun Yun Go; Raluca Dulgheru; Tadafumi Sugimoto; Stella Marchetta; Cécile Oury; Patrizio Lancellotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

6.  Assessment of mitral valve disease: a review of imaging modalities.

Authors:  Shweta R Motiwala; Francesca N Delling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-07

7.  Potential Role of Cardiopulmonary Exercise Testing as an Early Screening Tool for Patients With Suspected Pulmonary Hypertension Including Exercise-Induced Pulmonary Hypertension: Results From a Retrospective Analysis.

Authors:  Zulfiqar Qutrio Baloch; Shabber Agha Abbas; Rohan Madhu Prasad; Amin M Elamin; Abbas Ali
Journal:  Perm J       Date:  2021-06-09

8.  Prognostic value of exercise stress echocardiography in patients with secondary mitral regurgitation: a long-term follow-up study.

Authors:  Tomomi Suzuki; Masaki Izumo; Kengo Suzuki; Dan Koto; Maya Tsukahara; Kanako Teramoto; Yukio Sato; Mika Watanabe; Kei Mizukoshi; Ryo Kamijima; Manabu Takai; Seisyou Kou; Tomoo Harada; Sachihiko Nobuoka; Yoshihiro J Akashi
Journal:  J Echocardiogr       Date:  2018-10-29

Review 9.  Timing surgery in mitral regurgitation: defining risk and optimising intervention using stress echocardiography.

Authors:  Boyang Liu; Nicola C Edwards; Simon Ray; Richard P Steeds
Journal:  Echo Res Pract       Date:  2016-10-13

Review 10.  Left ventricular heart failure and pulmonary hypertension.

Authors:  Stephan Rosenkranz; J Simon R Gibbs; Rolf Wachter; Teresa De Marco; Anton Vonk-Noordegraaf; Jean-Luc Vachiéry
Journal:  Eur Heart J       Date:  2015-10-27       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.